Vaccine News and Research

Latest Vaccine News and Research

First computational model simulates many variables affecting COVID-19 transmission

First computational model simulates many variables affecting COVID-19 transmission

Study tests efficacy of molnupiravir against SARS-CoV-2 VOCs in various animal models

Study tests efficacy of molnupiravir against SARS-CoV-2 VOCs in various animal models

Researchers identify a potent new combination of antiviral drugs to combat SARS-CoV-2

Researchers identify a potent new combination of antiviral drugs to combat SARS-CoV-2

Newborn antibodies following maternal COVID-19 vaccination persist for up to six months

Newborn antibodies following maternal COVID-19 vaccination persist for up to six months

Impact of genetic changes in Omicron variant on an immunodominant T-cell epitope

Impact of genetic changes in Omicron variant on an immunodominant T-cell epitope

University of Michigan expert discusses about COVID-19 vaccine for kids under 5

University of Michigan expert discusses about COVID-19 vaccine for kids under 5

Exploring omicron infection in COVID-19 vaccinated and convalescent South African healthcare workers

Exploring omicron infection in COVID-19 vaccinated and convalescent South African healthcare workers

Study explores wastewater surveillance of US military installations to mitigate the spread of SARS-CoV-2

Study explores wastewater surveillance of US military installations to mitigate the spread of SARS-CoV-2

Philippines starts vaccinating children aged five to 11 against COVID-19

Philippines starts vaccinating children aged five to 11 against COVID-19

Study compares the neutralizing potential of antibodies against two Omicron variants

Study compares the neutralizing potential of antibodies against two Omicron variants

Single-cell sequencing provides detailed insight into early SARS-CoV-2 infection in the lungs

Single-cell sequencing provides detailed insight into early SARS-CoV-2 infection in the lungs

Induction and stability of vaccine-specific antibodies in multiple sclerosis patients on different disease-modifying therapies

Induction and stability of vaccine-specific antibodies in multiple sclerosis patients on different disease-modifying therapies

Study finds gender-based differences in risk factors associated with anxiety during the pandemic

Study finds gender-based differences in risk factors associated with anxiety during the pandemic

Simulation of SARS-CoV-2 spread in the United States and India

Simulation of SARS-CoV-2 spread in the United States and India

Study explores inflammation of endothelial cells by exosomes from COVID-19 patients

Study explores inflammation of endothelial cells by exosomes from COVID-19 patients

Integrated NHS and adult social care sector could improve care for all

Integrated NHS and adult social care sector could improve care for all

Study explores adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants post-immunization in cancer patients

Study explores adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants post-immunization in cancer patients

mRNA COVID-19 vaccines shown to provide high level of protection against severe SARS-CoV-2 omicron infection

mRNA COVID-19 vaccines shown to provide high level of protection against severe SARS-CoV-2 omicron infection

Effectiveness of COVID-19 vaccination 9 months post-vaccination for the population of Sweden

Effectiveness of COVID-19 vaccination 9 months post-vaccination for the population of Sweden

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.